(Q53068617)

11 May 2018

title

Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer. (English)

1 reference

11 May 2018

0 references

Michael Hauptmann

2

0 references

author name string

Joost L Knegjens

1

1 reference

11 May 2018

Frank A Pameijer

3

1 reference

11 May 2018

Alfons J Balm

4

1 reference

11 May 2018

Frank J Hoebers

5

1 reference

11 May 2018

Josien A de Bois

6

1 reference

11 May 2018

Johannes H Kaanders

7

1 reference

11 May 2018

Carla M van Herpen

8

1 reference

11 May 2018

Cornelia G Verhoef

9

1 reference

11 May 2018

Oda B Wijers

10

1 reference

11 May 2018

Ruud G Wiggenraad

11

1 reference

11 May 2018

Jan Buter

12

1 reference

11 May 2018

Coen R Rasch

13

1 reference

11 May 2018

publication date

1 March 2011

1 reference

11 May 2018

published in

Head & Neck

1 reference

11 May 2018

volume

33

1 reference

11 May 2018

issue

3

1 reference

11 May 2018

page(s)

375-382

1 reference

11 May 2018

Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer

cites work

1 reference

The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation

21 January 2018

1 reference

Tumor volume and local control probability: clinical data and radiobiological interpretations

21 January 2018

1 reference

ASA classification and perioperative variables as predictors of postoperative outcome

21 January 2018

1 reference

Analysis of prognostic factors of chemoradiation therapy for advanced hypopharyngeal cancer--does tumor volume correlate with central necrosis and tumor pathology?

21 January 2018

1 reference

The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer.

21 January 2018

1 reference

An evaluation of the variability of tumor-shape definition derived by experienced observers from CT images of supraglottic carcinomas (ACRIN protocol 6658).

21 January 2018

1 reference

21 January 2018

1 reference

7 January 2021

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

1 reference

7 January 2021

Combined concomitant boost radiotherapy and chemotherapy in stage III-IV head and neck carcinomas: a comparison of toxicity and treatment results with those observed after radiotherapy alone

1 reference

7 January 2021

Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma

1 reference

7 January 2021

Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials

1 reference

7 January 2021

Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT.

1 reference

7 January 2021

Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma

1 reference

7 January 2021

Dose, volume, and tumor-control predictions in radiotherapy

1 reference

7 January 2021

Tumor volume: a basic and specific response predictor in radiotherapy

1 reference

7 January 2021

The relation of CT-determined tumor parameters and local and regional outcome of tonsillar cancer after definitive radiation treatment

1 reference

7 January 2021

Quantitative analysis from CT is prognostic for local control of supraglottic carcinoma

1 reference

7 January 2021

Evaluation of pretreatment computed tomography as a predictor of local control in T1/T2 pyriform sinus carcinoma treated with definitive radiotherapy

1 reference

7 January 2021

Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies

1 reference

7 January 2021

High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer

1 reference

7 January 2021

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

1 reference

7 January 2021

Concurrent chemoradiation with daily low dose cisplatin for advanced stage head and neck carcinoma

1 reference

7 January 2021

Significance of tumor volume and corpus uteri invasion in cervical cancer patients treated by radiotherapy.

1 reference

7 January 2021

Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: impact of tumor volume

1 reference

7 January 2021

Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy

1 reference

7 January 2021

Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy

1 reference

7 January 2021

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

1 reference

7 January 2021

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

7 January 2021

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

1 reference

7 January 2021

Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy

1 reference

7 January 2021

Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging

1 reference

7 January 2021

Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm

1 reference

7 January 2021

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis

1 reference

7 January 2021

Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT)

1 reference

7 January 2021

Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review

1 reference

7 January 2021

Analysis of prognostic variables among patients with locally advanced head and neck cancer treated with late chemo-intensification protocol: impact of nodal density and total tumor volume

1 reference

7 January 2021

Variability of tumor volumes in T3-staged head and neck tumors

1 reference

7 January 2021

Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy

1 reference

7 January 2021

Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen

1 reference

7 January 2021

Measurement by multidetector CT scan of the volume of hypopharyngeal and laryngeal tumours: accuracy and reproducibility.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.21459

1 reference

11 May 2018

PubMed ID

20629076

1 reference

11 May 2018